Skip to content
Bio.News is heading back to San Francisco for the Biotechnology Innovation Organization (BIO) Investor Forum, one of the only independent partnering events dedicated to […]
How to follow the 2024 BIO Investor Forum in San Francisco Read More »
Colorado’s efforts to impose price controls on prescription drugs are preempted by federal law, according to a legal brief by the Biotechnology Innovation Organization
Colorado price-setting board conflicts with federal law, BIO tells court Read More »
As climate change threatens crops and shifts growing areas, maintaining food security requires the kinds of improvements to plant and animal farming that biotech
Biotech bolsters food security amid climate challenges: I am BIO Podcast Read More »
Medicare beneficiaries will soon need to begin thinking about their coverage for 2025, with the open enrollment period opening on Oct. 15. The next
As Medicare open enrollment nears, ‘M3P’ and the out-of-pocket cap loom large Read More »
September was a big month for those following antimicrobial resistance (AMR). A new study highlighted the growing public health burden of AMR, and the
AMR continues to pose a global threat Read More »
Food and Drug Administration (FDA) inaction on patents for drug delivery devices has been troubling drug manufacturers for 20 years, and the situation is
Sen. Cassidy calls on FDA to act, not abdicate, on drug device patents Read More »
As Claudia Sheinbaum became Mexico’s president on Oct. 1, a bipartisan letter from 21 American Congress members called on U.S. officials to resolve the
As Mexico changes presidents, House members urge action on corn ban Read More »
Mpox has proven to be a major public threat since its resurgence globally during the COVID years. As Bio.News reported, “On Aug. 14, the
BIO speaks on Capitol Hill about mpox preparedness Read More »
With the 118th Congress wrapping up in a few months, the Biotechnology Innovation Organization (BIO) continues its work to improve policy that impacts the
What to know about BIO’s 7 Core Strategic Priorities Read More »
Going from “we have a problem” to “we have an idea” to “we have a solution” is an important journey for patient advocates and
